The generic name for Vyvanse is lisdexamfetamine dimesylate [1]. Lisdexamfetamine is a prodrug of dextroamphetamine, meaning it is converted to dextroamphetamine in the body [2].
How does lisdexamfetamine dimesylate work?
Lisdexamfetamine dimesylate is a central nervous system stimulant that is thought to affect neurotransmitter levels in the brain, particularly dopamine and norepinephrine [2]. It is prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in both children and adults, as well as moderate to severe binge-eating disorder in adults [1].
When did Vyvanse lose its patent exclusivity?
The original patent for Vyvanse was set to expire, but there have been various legal challenges and extensions related to its patent protection [3]. Information regarding specific patent expiry dates and ongoing litigation can be found on resources like DrugPatentWatch.com [3].
Who makes generic versions of Vyvanse?
Once patent exclusivity ends, multiple pharmaceutical companies can begin manufacturing and selling generic versions of a drug. Information about which companies are approved to market generic lisdexamfetamine dimesylate can be found through regulatory agencies and pharmaceutical databases [4].
What are the side effects of lisdexamfetamine dimesylate?
Common side effects associated with lisdexamfetamine dimesylate can include decreased appetite, dry mouth, insomnia, weight loss, and increased heart rate [1]. More serious side effects can occur, and individuals should consult with a healthcare professional regarding potential risks [1].
How does lisdexamfetamine compare to other ADHD medications?
Lisdexamfetamine is a stimulant medication, similar to methylphenidate-based drugs and other amphetamine-based medications. It is a prodrug formulation, which is designed to release the active ingredient more gradually throughout the day. This can potentially lead to a smoother effect and a reduced potential for abuse compared to immediate-release amphetamines [2].
Can lisdexamfetamine be used for other conditions?
Currently, lisdexamfetamine dimesylate is approved for the treatment of ADHD in children and adults and for binge-eating disorder in adults [1]. Its mechanism of action suggests potential for other psychiatric conditions, but these are not current approved indications.
What is the difference between Vyvanse and Adderall?
Both Vyvanse (lisdexamfetamine dimesylate) and Adderall (amphetamine and dextroamphetamine salts) are stimulant medications used to treat ADHD. The primary difference lies in their chemical composition and how they are metabolized. Vyvanse is a prodrug that is converted to dextroamphetamine, while Adderall is a mixture of amphetamine and dextroamphetamine salts [2].
What are the risks associated with stimulant medications like lisdexamfetamine?
Stimulant medications, including lisdexamfetamine, carry risks such as potential for cardiovascular problems, psychiatric issues, and a risk of misuse or dependence [1]. Healthcare providers carefully assess patients for these risks before prescribing these medications.
Sources:
1. https://www.drugs.com/vyvanse.html
2. https://www.rxlist.com/vyvanse-drug.htm
3. https://drugpatentwatch.com/
4. https://www.fda.gov/